TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
10x Genomics Sweden AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
179,704
|
171,257
|
115,743 |
| Financial expenses |
210
|
5
|
9 |
| Earnings before taxes |
103,325
|
90,766
|
54,816 |
| EBITDA |
109,743
|
97,135
|
56,851 |
| Total assets |
248,675
|
174,010
|
98,627 |
| Current assets |
235,886
|
155,154
|
78,902 |
| Current liabilities |
23,675
|
37,559
|
28,485 |
| Equity capital |
225,001
|
136,451
|
70,142 |
| - share capital |
34
|
33
|
36 |
| Employees (average) |
39
|
45
|
38 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
90.5%
|
78.4%
|
71.1% |
| Turnover per employee |
4,608
|
3,806
|
3,046 |
| Profit as a percentage of turnover |
57.5%
|
53.0%
|
47.4% |
| Return on assets (ROA) |
41.6%
|
52.2%
|
55.6% |
| Current ratio |
996.4%
|
413.1%
|
277.0% |
| Return on equity (ROE) |
45.9%
|
66.5%
|
78.2% |
| Change turnover |
7,564
|
64,889
|
59,312 |
| Change turnover % |
4%
|
61%
|
105% |
| Chg. No. of employees |
-6
|
7
|
18 |
| Chg. No. of employees % |
-13%
|
18%
|
90% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.